I’m pleased to report that we have already amassed health and genomic data on 265 children and young adults with A-T through our on-line Global A-T Family Data Platform. Contributing families span 25 countries, facilitated by the portal’s functionality in 10 languages.

Now, research scientists have begun plunging into these de-identified data sets, seeking discoveries both to improve the management of disease symptoms and to develop new therapies for A-T, all the while increasing our understanding of A-T. And, overseen by A-T parents from around the world, a team of distinguished scientists and clinicians on our Data Access Committee have begun selectively granting access to researchers who are planning unique data analysis projects.

This progress is only the beginning, and we know already that this data platform will have a tremendous impact. But, the more data sets we have, the better and faster will be the discoveries that emerge. We are therefore eager to continue finding and encouraging A-T families around the world to join the platform.

If you’d like to participate as either a family member or a researcher, please visit atfamilies.orgtoday. Thank you.

Brad Margus
Volunteer Chairman and Founder

Contact Us

Related News

Feb 15 @ 5:08 pm

Race with the A-T CureTeam at Disney!

Announcing the CureTeam's Walt Disney World race schedule!

more
Feb 15 @ 5:08 pm

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
Feb 15 @ 5:08 pm

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more
Feb 15 @ 5:08 pm

Encouraging News from an A-T Clinical Trial

IntraBio announced positive results from its pivotal Phase III clinical trial of a drug for children and adults

more